+1-786-628-7980
Sign Up/Sign In 
Market Overview
Intravenous solution market Research Report Information By Nutrition Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml) and Small Volume Bags (<250 ml)), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion, and Others), By End User (Hospital & Clinics, Ambulatory Surgical Centers, and Home Care), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.
The Intravenous solution market Size was valued at USD 12.87 billion in 2023 and is projected to grow from USD 13.64 Billion in 2024 to USD 27.98 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.12% during the forecast period (2024 – 2032).
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1235
Market Trends
New intravenous injection solutions introduced by market participants are expected to drive the growth of the global intravenous solutions market in the coming years. For example, Baxter International Inc., a global leader in sterile medication production, announced the FDA approval and commercial launch of premix Bitartrate in 5% Dextrose Injection. This medication is prescribed to raise blood pressure in adults with severe, acute hypotension and is available in four different strengths, making it the first ready-to-use formulation of its kind.
Key market players are also launching parenteral (intravenous) nutrition (PN) products, further propelling market growth. For instance, Eurolife Healthcare introduced intravenous IV products Lifeport and Discport, designed to reduce the risk of infection through advanced technology.
The increasing prevalence of malnutrition, along with the shorter response time and higher efficacy of intravenous solution therapy, is also contributing to the expansion of the intravenous solution market.
Market Segment
Intravenous Solution Nutrition Type
The intravenous solution market is segmented by nutrition type into peripheral and total parenteral nutrition. The total parenteral nutrition (TPN) segment holds the largest share of the market, driven by its higher adoption for patients who do not receive any other form of nutrition.
Intravenous Solution Bag Type
Based on bag type, the market is divided into large-volume bags (>250 ml) and small-volume bags (<250 ml). The small-volume bags segment has the largest global market revenue share.
Intravenous Solution Nutritional Content
The market segmentation by nutritional content includes amino acid solutions, carbohydrates, vitamins & minerals, parenteral lipid emulsion, and others. The amino acid solution segment commands the highest revenue share due to the rising prevalence of nutrient deficiencies and hepatic diseases, along with increased consumption of amino acid injections.
Buy Now Premium Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1235
Intravenous Solution End User
End user segments the market into hospitals & clinics, ambulatory surgical centers, and home care. The hospitals & clinics segment holds a significant market revenue share, attributed to the growing number of hospitals and clinics and the increasing prevalence of metabolic problems.
Intravenous Solution Regional Insights
North America
The North American intravenous solution market is expected to grow significantly during the projection period. This growth is driven by an increase in the geriatric population, rising incidence of chronic diseases, and the industry’s expansion to meet demands caused by the flu and coronavirus pandemics. North America’s well-established healthcare infrastructure has led to increased demand for IV treatment throughout various stages, such as emergency care or surgery.
Europe
Europe holds the second-largest intravenous solution market globally. The region’s aging population and the correlating growth of the patient pool contribute to increasing intravenous solution sales. Key factors include a large patient population, strong presence of key players, easy drug availability, well-developed healthcare systems, and favorable reimbursement policies. Technological advancements and government assistance for national health services and insurance are also expected to drive market growth. The U.K. holds the largest market share in Europe, with France being the fastest-growing market in the region.
Asia-Pacific
The Asia-Pacific intravenous solution market is predicted to expand at the fastest rate during the forecast period. High expenditure by both public and private entities in research, technological advancements, and an increasing number of collaborative relationships between stakeholders, such as the healthcare community and universities, drive this region’s rapid growth. Additionally, the rising prevalence of chronic diseases due to unhealthy food consumption patterns and the growing preference for cost-effective care are important factors anticipated to boost market growth in the Asia-Pacific region.
Major Countries Covered
The major countries covered in the intravenous solution market include the United States, Germany, France, Canada, the United Kingdom, India, Spain, Italy, Japan, Australia, China, South Korea, and Brazil.
Browse In-depth Market Research Report (124 Pages) on Intravenous Solution: https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235
Competitive Dynamics
MRFR recognizes the following companies as the key players in the global IV solutions market—Baxter International Inc. (US), Fresenius SE & Co. KGaA (Germany), B. Braun Melsungen AG (Germany), ICU Medical, Inc. (US), Pfizer Inc. (US), Grifols S.A. (Spain), Terumo Medical Corporation (Japan), and Amanta Healthcare (India).
Discover More Research Reports on Healthcare Industry by Market Research Future:
Dietary Supplements in the Age of Personalized Nutrition Market Research Report Information By Product Category (Vitamins and Herbs & Botanicals), By Application (Lifestyle Diseases and Inherited Disease), By Gender (Female and Male), By Dosage Form (Capsules, Powder, Liquids, Soft Gels, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.
Chronic Kidney Disease Market Research Report Information by Diagnosis (Blood Test, Urine Test, Imaging Test, and Kidney Biopsy), by Treatment (Drugs, Dialysis, and Kidney Transplant) , by Indication (Type 1 Or Type 2 Diabetes, High Blood Pressure, and Polycystic Kidney Disease), by End User (Hospital & Clinics and Diagnostic Centers), by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Forecast till 2032.
Ophthalmic Drugs Market Research Report Information by Dosage Form (Eye Drops, Eye Ointments, Eye Solutions, Gels, Capsules & Tablets and others), Product Type (Prescription Drug and OTC Drug), Drug Class (Antibiotics, Anti-Inflammatory, Anti-Glaucoma and others), Indication (Glaucoma, Retinal Disorder, Dry Eye, Eye Allergy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2032.
Digital Therapeutic Market Research Report Information By Product Type (Software, Devices, Others), By Application (Cardiovascular Diseases, Obesity, Diabetes, Respiratory Diseases, Smoking Cessation, Others), By Sales Channel (B2B, B2C), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.
Extremity Products Market Research Report Information By Product (Upper Extremity and Lower Extremity), By Material (Metallic Material, Ceramic Material, Polymeric Material, and Natural Material), and By Region (North America, Europe, Asia-Pacific, and Rest of The World) – Market Forecast Till 2032.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
